Search results for: 'api water'

CDMOs are third-party vendors that offer outsourced development and manufacturing services for pharmaceutical drugs. In the small molecule manufacturing sector, CDMOs provide expert development and manufacturing services and are now an essential part of the pharmaceutical industry's value chain. The growing incidence of chronic diseases propels t...

The expansion of embedded payment to new domains and process automation are great opportunities for growth in the Asia-Pacific Real-Time Payment (RTP) Monetization market. Technology advances in online payment and the development of cloud and API-based solutions are transforming the industry and its processing workflows. As a result, businesses wil...

14 Oct 2021  |  Asia Pacific  |  Market Research

Southeast Asian Contactless Payment Growth Opportunities, Forecast to 2026

Convenience and Safety Considerations During the Pandemic Drive Use

Infographics

×

The proliferation of COVID-19 has factored into the growth of contactless payments (made through a mobile device, wearable, or physical or virtual card, with the payee’s device or a merchant’s terminal initiating the transaction) in Southeast Asia. Customers want a safe and convenient way to do face-to-face transactions. Regulations and other gover...

Frost & Sullivan defines Communications Platforms as a Service (CPaaS) as any cloud-based platform that enables developers to programmatically embed voice, video, chat, and messaging services within their business or consumer applications. In nearly all cases, the embedded communications and collaboration services leveraged through a CPaaS are a fe...

This Frost Radar benchmarks companies and their solutions that enable the exchange and use of data between healthcare applications. Interoperability improves continuity of care, increases communication and connectivity between different stakeholders (e.g., payors, providers, patients, public health bodies), and reduces inefficiencies. Organizat...

Europe’s life sciences sector is approaching a defining inflection point in 2026, as major regulatory and policy reforms converge to reshape pharma, diagnostics, life sciences IT, biotechnology, and the bioeconomy. Together, these frameworks open clear growth pathways across the value chain: the Clinical Trials Regulation (CTR) and European Health ...

This study provides a comprehensive analysis of the contract research and manufacturing services (CRAMS) segment in India by focusing on drug discovery to pre-clinical toxicology, Active Pharmaceutical Ingredient (API), Formulations and Injectables. The study is based on detailed primary research, and includes an evaluation of the market size as we...

The pharma industry is one of the fastest growing industry sectors in India today, and the demand for APIs and intermediates in India is higher than ever. This research service talks about the Indian pharmaceutical intermediates market, focusing on top-selling therapy segments. It analyses the demand for intermediates in each segment, drivers, rest...

In today’s turbulent economic conditions and the challenges brought about by the global COVID-19 pandemic, geopolitical chaos and supply chain gluts have affected investor sentiment. Delays in new project investment, concerns of low RoI, and high operational expenses, especially in the oil and gas upstream sector and the chemical process, power gen...